We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

REGCP:NASDAQRegency Centers Corporation - 6.25% Series A Cumulative Redeemable Preferred Stock Analysis

Data as of 2026-04-28 - not real-time

$23.02

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

Regency Centers Corp (REGCP) is trading at $23.02, below its 20‑day ($23.17) and 50‑day ($23.19) simple moving averages, with a bearish MACD histogram and a neutral RSI of 44, signaling short‑term downside momentum. Volume has been trending lower and the 30‑day volatility sits at ~12.4%, indicating a modestly choppy price environment. Fundamentally, the REIT delivers strong operating metrics – 8.9% revenue growth, gross margin above 70% and operating margin near 39% – yet it carries a very high debt‑to‑equity ratio of 69.4 and reports zero earnings per share, resulting in undefined P/E ratios. The stock’s price‑to‑book of 0.63 suggests it is priced well below its net asset value, while the dividend yield of 6.79% is attractive but its sustainability is questionable given the lack of earnings and a reported payout ratio of 0.
The low computed beta (~0.12) points to limited market‑wide price sensitivity, but the decreasing liquidity and heavy leverage elevate financial and liquidity risk. With the REIT sector facing retail‑footfall headwinds, regulatory and sector‑specific risks remain medium, while geographic exposure is confined to the United States, keeping currency risk low. Overall, the mix of attractive valuation metrics and high debt creates a nuanced risk‑return profile that leans toward cautious positioning.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 4/10

Key Factors

  • Bearish technical indicators (price below SMAs, negative MACD)
  • Decreasing trading volume
  • Uncertainty around dividend sustainability

Medium Term

1–3 years
Neutral
Model confidence: 5/10

Key Factors

  • Strong operating margins and revenue growth
  • High leverage (debt‑to‑equity ~69)
  • Undervalued price‑to‑book ratio

Long Term

> 3 years
Positive
Model confidence: 7/10

Key Factors

  • Significant discount to book value
  • Potential for balance‑sheet deleveraging over time
  • Attractive dividend yield if earnings improve

Key Metrics & Analysis

Financial Health

Revenue Growth8.90%
Profit Margin32.74%
ROE7.68%
ROA3.15%
Debt/Equity69.39
P/B Ratio0.6
Op. Cash Flow$827.7M
Free Cash Flow$671.5M
Industry P/E33.2

Technical Analysis

TrendBearish
RSI44.4
Support$22.35
Resistance$23.56
MA 20$23.17
MA 50$23.19
MA 200$23.61
MACDBearish
VolumeDecreasing
Fear & Greed Index89.25

Valuation

GradeUndervalued
TypeBlend
Dividend Yield6.79%

Risk Assessment

Beta0.12
Volatility12.39%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.